Business
T. Rowe Price Seeks Approval for First Crypto ETF Launch
T. Rowe Price has filed for regulatory approval to launch its first actively managed exchange-traded fund (ETF) focused on multiple digital currencies. This announcement came on October 25, 2023, as the firm aims to enter the cryptocurrency market, marking its first significant step into this space nearly two years after the U.S. Securities and Exchange Commission (SEC) approved spot bitcoin ETFs.
Analyst Bryan Armour from Morningstar described the firm’s late entry into the market as surprising, noting that T. Rowe Price plans to offer unique features to differentiate itself in a crowded field. While many asset managers have submitted applications for ETFs linked to individual cryptocurrencies, proposals for new multi-coin products, especially those that are actively managed, remain uncommon.
The proposed ETF intends to provide investors exposure to a selection of between five and 15 digital currencies, which may include popular options such as bitcoin, ether, solana, dogecoin, and Shiba Inu as outlined in the prospectus. The fund will aim to outperform the FTSE Crypto US Listed Index, using a combination of fundamental, valuation, and momentum factors to select assets and determine their respective weights in the portfolio.
As traditional mutual fund outflows continue, T. Rowe Price is actively seeking to diversify its offerings. The firm has launched 24 ETFs in recent years and, just last month, announced a partnership with Goldman Sachs to explore innovative private market products for retail investors. As part of this collaboration, Goldman Sachs indicated it would acquire up to 3.5 percent of T. Rowe Price’s shares, a potential investment amounting to over $1 billion.
“This is a firm looking for new niches,” Armour emphasized, highlighting T. Rowe Price’s commitment to exploring emerging markets. Over the past few years, the company has been closely monitoring the developments in the digital assets sector, having established the capability to trade these assets. In 2022, the firm appointed Blue Macellari, a former executive from a cryptocurrency hedge fund, as the head of its digital assets strategy.
Industry experts are optimistic about the expansion of T. Rowe Price’s ETF lineup. Todd Rosenbluth, head of research at ETF market analysis firm VettaFi, expressed excitement over the firm’s move beyond traditional stock and bond exposure.
Currently, numerous cryptocurrency ETFs are awaiting SEC approval. However, the ongoing government shutdown has reduced the agency’s staffing, which may delay the approval process for these products, including the T. Rowe Price ETF. Despite the SEC’s recent adoption of new listing standards, which could pave the way for various new offerings, the timeline for approval remains uncertain until the government reopens.
In summary, T. Rowe Price’s foray into the cryptocurrency ETF market signals a strategic shift for the firm as it seeks to adapt to evolving investment landscapes and meet the growing demand for diversified digital asset exposure.
-
Sports2 months agoRegina Martinez Breaks New Ground for Mexico in Cross-Country Skiing
-
World6 months agoSouth Korea’s Foreign Minister Cho Hyun to Visit China This Week
-
Business7 months agoStarling Bank Plans Secondary Share Sale, Targeting $5.4 Billion Valuation
-
Top Stories7 months agoMunsang College Celebrates 100 Years with Grand Ceremony
-
World6 months agoPAS Aims to Expand Parliamentary Influence in Upcoming Election
-
Sports8 months agoDe Minaur Triumphs at Washington Open After Thrilling Comeback
-
Business8 months agoKenvue Dismisses CEO Thibaut Mongon as Strategic Review Advances
-
Lifestyle8 months agoHumanism Camp Engages 250 Youths in Summer Fest 2025
-
Top Stories8 months agoColombian Senator Miguel Uribe Shows Signs of Recovery After Attack
-
Sports8 months agoTupou and Daugunu Join First Nations Squad for Lions Clash
-
World8 months agoASEAN Gears Up for Historic Joint Meeting of Foreign and Economic Ministers
-
Health8 months agoNew Study Challenges Assumptions About Aging and Inflammation
